Abstract
Clinical dose reduction is achieved through potentiation, which is the process used to manufacture homeopathic medicine with varying potencies. In this study, we used 2–6 µm mid-infrared wavelength radiation to further amplify commercially available homeopathic medicines, such as thuja (Thuja occidentalis), a medication frequently used for a variety of ailments. We invented an emitter called MIRGA (mid-infrared generating atomizer) for potentiation purpose. The benefits of mid-IR potentiation include a reduction of the clinical dose, host stress, and resource and cost savings. The effects of irradiation on Thuja in chemical bond alterations and configurations are proven here by scientific instrumentations.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
